Provider
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Documents & Forms Results
Displaying 41 - 50 of 3279 results
Provider
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Oral Anticoagulant - Medicaid
Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Ophthalmic Antihistamine - Commercial
Step Therapy
Program effective Date: Sep 01, 2025
Provider
Morphine Equivalent Dosing (MED) - Medicaid
Prior Authorization
Program effective Date: Sep 01, 2025
Provider
Saxenda Wegovy Zepbound - Commercial
Coverage Exception, Formulary Exception, Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Xdemvy - Commercial
Step Therapy, Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Pyrukynd (mitapivat) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Pyrukynd (mitapivat) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Vascepa - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025